3Galetta D ; C, ebbia V ; Silvestris N Cisplatin, fotemustine and whole-brainradiotherapyinnan-small cellung cancer patients with asymptomatic brain metastases:A multicenter phase II study of the GruppoOncologico Italia Meridionale (GOIM 2603)2011 (01).
4Bajard A;Westeel V Muhivariate analysis of factors predictive of brain metastases in localized non-small cell lung carcinoma [ 外文期刊]2004(3) doi: 10.1016/j.lungcan.2004.01.025.
4Bobinet G, Thomas P, Bretan JL, et al. Results of phase Ⅲ study of early venus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non- small-cell lunn cancer:Groupe Francais de pneumo cancerolonie (GFPC) protocol 951. Ann Oncol, 2001,12:59.
6Eiehler AF, Loeffler JS. Multidisciplinary management of brain metastases. Oncologist, 2007, 12:884-898.
7Cortot AB, Geriniere L, Robinet G, et al. Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases: a GLOT-GFPC study. Ann Oncol, 2006, 17 : 1412-1417.
8Addeo R, De Rosa C, Faiola V, et al. Phase 2 trial of temozolomide using protracted low-dose and whole-brain radiotherapy for nonsmall cell lung cancer and breast cancer patients with brain metastases. Cancer, 2008, 113:2524-2531.
9Dziadziuszko R, Ardizzoni A, Postmus PE, et al. Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases, a phase II study of the EORTC Lung Cancer Group (08965). Eur J Cancer, 2003, 39 : 1271-1276.
10Kris MG, Natale RB, Herbst RS, et al. Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase,in symptomatic patients with non-small cell lung cancer: a randomized trial. JAMA,2003,290(16): 2149-2158.
